Paragon Associates & Paragon Associates Ii Joint Venture Iridex Corp Transaction History
Paragon Associates & Paragon Associates Ii Joint Venture
- $39.7 Million
- Q1 2025
A detailed history of Paragon Associates & Paragon Associates Ii Joint Venture transactions in Iridex Corp stock. As of the latest transaction made, Paragon Associates & Paragon Associates Ii Joint Venture holds 1,000,000 shares of IRIX stock, worth $970,000. This represents 2.49% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 1,000,000
-0.0%
Holding current value
$970,000
Previous $1.7 Million
41.76%
% of portfolio
2.49%
Previous 4.0%
Shares
10 transactions
Others Institutions Holding IRIX
# of Institutions
25Shares Held
3.12MCall Options Held
0Put Options Held
2K-
Vanguard Group Inc Valley Forge, PA595KShares$576,9430.0% of portfolio
-
Amh Equity LTD519KShares$502,9840.83% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$367,7850.0% of portfolio
-
Geode Capital Management, LLC Boston, MA133KShares$129,1110.0% of portfolio
-
Ars Investment Partners, LLC110KShares$106,7580.01% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $15.5M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...